Features Screener Stocks Charts
Sign In Sign Up

Cadila Healthcare Ltd. Cash Flow Statement

NSE:CADILAHC | PHARMACEUTICALS

Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.

View Plans

Cash Flow Insights

Cash Conversion

1.12x

CADILAHC's operating cash flow exceeded net income in FY 2025, indicating earnings are backed by actual cash generation.

Free Cash Flow

₹50.64B

CADILAHC's free cash flow was ₹50.64B in FY 2025, up 121.2% from FY 2024.

Dividend Coverage

16.7x

CADILAHC's free cash flow covered dividends 16.7x in FY 2025, leaving room for reinvestment or debt reduction.

CapEx Intensity

25.3%

Capital expenditure was 25.3% of operating cash flow in FY 2025 for CADILAHC, indicating a capital-light business.

2-year CADILAHC cash flow snapshot

Hover the chart icon for YoY change.

FY 2024 - FY 2025
Item Chart 2024 2025
Net Income 48.38B 60.27B
Cash flow Operating Activities 31.96B 67.77B
Investments in PPE -9.07B -17.13B
Cash flow Investing Activities -14.75B -83.72B
Dividend Paid -6.21B -3.03B
Cash flow Financing Activities -17.79B 20.14B
Cash at beginning of period 4.88B 4.13B
Cash at end of period 4.13B 8.27B
Free Cash Flow 22.90B 50.64B

Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹).

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025